Risk of cerebral palsy in term-born singletons according to growth status at birth

Magnus Odin Dahlseng1, Guro L Andersen, Lorentz M Irgens

  • 1Department of Laboratory Medicine, Children's and Women's Health, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway.

Insights

Birth size measurements are linked to cerebral palsy (CP) risk. Both small and large infants, particularly those with abnormal length or head circumference, face increased CP incidence, suggesting varied causes.

Area of Science:

  • Neonatal research
  • Pediatric neurology
  • Public health

Background:

  • Cerebral palsy (CP) risk is elevated in infants with low or high birthweight.
  • Limited research exists on the association between other anthropometric measurements at birth and CP risk.

Purpose of the Study:

  • To investigate the relationship between various birth size measurements and the incidence of cerebral palsy in term-born singletons.

Main Methods:

  • Utilized data from the Medical Birth Registry of Norway (1996-2006) for term-born singletons.
  • Calculated z-scores for weight, length, head circumference, and ponderal index.
  • Compared measurements of 398 infants with CP to 490,022 typically developing infants.

Main Results:

  • Low birthweight, low/high length z-scores, and low/high head circumference z-scores were associated with increased CP risk, especially spastic bilateral CP.
  • Spastic unilateral CP was linked to low z-scores for length and head circumference.
  • Large infants with low ponderal index had higher risks of spastic quadriplegic and dyskinetic CP.

Conclusions:

  • Findings suggest most CP subtypes stem from poor intrauterine growth (antenatal factors).
  • CP in large newborns may be more associated with intrapartum complications.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
19.4K
Neurulation01:30

Neurulation

Neurulation is the embryological process which forms the precursors of the central nervous system and occurs after gastrulation has established the three primary cell layers of the embryo: ectoderm, mesoderm, and endoderm. In humans, the majority of this system is formed via primary neurulation, in which the central portion of the ectoderm—originally appearing as a flat sheet of cells—folds upwards and inwards, sealing off to form a hollow neural tube. As development proceeds, the...
40.4K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.1K